Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Biogen Inc. et al v. Creative Biolabs Inc.
Case Number:
1:20-cv-10543
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 14, 2020
Biogen Thwarts 'Brazen' Drug Copycat With IP Settlement
Biogen Inc. has secured a settlement blocking what it called a New York bioscience company's "brazen" effort to sell copycat versions of its potential blockbuster Alzheimer's drug, according to a Wednesday filing in Massachusetts federal court.
-
March 18, 2020
Biogen Sues Over 'Copycat' Alzheimer Treatment Products
Biogen Inc. hit a New York biotech company with a patent and trademark infringement suit Wednesday, alleging it is selling "copycat" products similar to a therapeutic antibody Biogen is developing to treat Alzheimer's disease, which has cost it hundreds of millions of dollars to develop.